The global cell therapy market is due to grow at a CAGR
of 10.6% during the forecast period of 2017 to 2023 according to Market
Research Future's latest report on the subject. Cell therapy has emerged as a
transformative field in biotechnology due to its use for the targeting of
various diseases at a cellular level. The above-average growth expected by this
market will primarily be due to the rapidly advancing healthcare sector and
growing breakthrough research and development activities.
Cell therapy is finding a growing number of
applications in healthcare and is often used in combination with gene therapy.
Presently, applications of cell therapy include urinary problems, cancers,
autoimmune disease, and infectious disease among several others. The growing
prevalence of chronic and lifestyle diseases is an important driver for the
cell therapy market. Cell therapy is also being developed in regenerative
medicine which carries massive potential once it clears the research phase.
Increasing geriatric population with health issues and technological
advancements are some other factors governing market growth. government
assistance for research and improvements being made in existing regulatory
frameworks are expected to pave the way for future market opportunities.
However, it should be noted that the high cost of
manufacturing at present and the lack of awareness or appropriate healthcare
infrastructure are expected to challenge market growth.
The Cell therapy market is expected to grow at a
CAGR 10.6% during the forecast period of 2017-2023.
A number of factors such as increasing geriatric
population, increasing government assistance, replacement of animal testing
model, technological advancements, and improvement in the regulatory framework,
are propelling the growth of cell therapy market. Rising prevalence of chronic
disorders is also fuelling up the market to a great extent.
Despite these drivers, there are some issues
associated with cell therapy market. Challenges in research and development,
the high cost of manufacturing, and poor healthcare system in low and
middle-income countries may hamper the growth of the market.
Cell
Therapy Market Major Key Players
·
Novartis
AG
·
GlaxoSmithKline
plc
·
MEDIPOST
·
Osiris
·
PHARMICELL
·
NuVasive,
Inc.
·
JCR
Pharmaceuticals Co., Ltd
·
ANTEROGEN.CO.,LTD.
·
Cynata
·
CELLECTIS
·
BioNTech
IMFS
·
EUFETS
GmbH
·
Cognate
·
PluristemGrupo
Praxis
·
Genzyme
Corporation
·
Advanced
Tissue and others.
Cell
Therapy Market Segmentation
The cell
therapy market is segmented on the basis of type, technology, cell source,
application, and end-user.
On the
basis of type, the market is segmented into autologous, and allogeneic.
On the
basis of technology, the market is classified into somatic cell technology,
cell immortalization technology, viral vector technology, genome editing
technology, cell plasticity technology, and three-dimensional technology. Viral
vector technology is further segmented into Ex vivo gene modification of cells
and In vivo gene modification of cells.
On the
basis of cell source, the market is classified into induced pluripotent stem
cells (iPSCs), bone marrow, umbilical cord blood-derived cells, adipose tissue,
and neural stem cell.
On the
basis of application, the market is classified into musculoskeletal,
cardiovascular, gastrointestinal, neurological, oncology, dermatology, wounds
and injuries, ocular, and others.
On the
basis of end-users, the market is segmented into hospital & clinics,
regenerative medicine centers, diagnostic centers, research institutes, and
others.
Cell
Therapy Market Regional Analysis
The
Americas dominate the cell therapy market owing to the rise in awareness among
people, and high healthcare expenditure.
Europe
holds the second position in cell therapy market. It is expected that the
support provided by government bodies for research & development and
improvement in reimbursement policies in healthcare will drive the market in
Europe region. On August 30, 2017. Novartis AG, A Switzerland based market
leader, received FDA approval for Kymriah suspension for intravenous infusion.
It is the first chimeric antigen receptor T cell therapy (CAR-T).
The
Asia Pacific is the fastest growing cell therapy market owing to the huge
patient pool and developing healthcare technology.
Detailed Table
of Contents:
Chapter 1. Report
Prologue
Chapter 2. Market
Introduction
2.1 Definition
2.2 Scope Of The Study
2.2.1 Research Objective
2.2.2 Assumptions
2.2.3 Limitations
LIST OF TABLES
Table 1 Cell Therapy Industry Synopsis, 2017 – 2023
Table 2 Cell Therapy Market Estimates And Forecast, 2017 – 2023,
(USD Million)
Table 3 Cell Therapy Market By Region, 2017 – 2023, (USD
Million)
Table 4 Cell Therapy Market By Type, 2017 – 2023, (USD Million)
LIST OF FIGURES
Figure 1 Research Process
Figure 2 Segmentation For Cell Therapy Market
Figure 3 Segmentation Market Dynamics For Cell Therapy Market
Figure 4 Global Cell Therapy Market Share, By Type 2016
...Continued
About US:
Market Research
Future (MRFR), enable customers to unravel the complexity of various industries
through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw
Research Reports (3R), Continuous-Feed Research (CFR), and Market Research
& Consulting Services.
Contact Us:
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune - 411028
Maharashtra, India
Phone: +1 646 845 9312
Email:
sales@marketresearchfuture.com
No comments:
Post a Comment